XTL Biopharmaceuticals Ltd. American Depositary Shares (XTLB) is a publicly traded Healthcare sector company. As of May 21, 2026, XTLB trades at $2.52 with a market cap of $6.39M and a P/E ratio of 0.00. XTLB moved -2.57% today. Year to date, XTLB is +1.34%; over the trailing twelve months it is -43.64%. Its 52-week range spans $2.12 to $10.28. Rallies surfaces XTLB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded XTLB stock?
Rallies tracks politician and congressional stock disclosures for XTLB, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
EDELMAN JOSEPH sold 9.60M (~$1.47M) on Nov 19, 2008.
EDELMAN JOSEPH sold 24.68M (~$3.48M) on Nov 18, 2008.
EDELMAN JOSEPH sold 2.70M (~$412.02K) on Nov 18, 2008.
XTLB Analyst Consensus
XTLB analyst coverage data. Average price target: $0.00.
Common questions about XTLB
Which politicians traded XTLB stock?
Rallies tracks politician and congressional stock disclosures for XTLB, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in XTLB?
Yes. Rallies tracks politician and congressional stock disclosures for XTLB, including reported purchases, sales, dates, owners, and trade amounts when available.
Is XTLB research on Rallies investment advice?
No. Rallies provides research, data, and educational context for XTLB. It does not provide personalized investment advice.
